Weight change and incident metabolic syndrome in Iranian men and women; A 3 year follow-up study

BMC Public Health

Volumn 9, Issue , 2009, Pages

  Zabetian, Azadeh ^a   Hadaegh, Farzad ^a   Sarbakhsh, Parvin ^a   Azizi, Fereidoun ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; IRAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORBIDITY; RISK FACTOR; WAIST CIRCUMFERENCE; WEIGHT CHANGE; WEIGHT REDUCTION; BLOOD; HEALTH BEHAVIOR; MIDDLE AGED; MOTOR ACTIVITY; MULTIVARIATE ANALYSIS; WEIGHT GAIN;

ADULT; BODY MASS INDEX; FEMALE; FOLLOW-UP STUDIES; HEALTH BEHAVIOR; HUMANS; IRAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MOTOR ACTIVITY; MULTIVARIATE ANALYSIS; RISK FACTORS; WEIGHT GAIN; WEIGHT LOSS;

EID: 67650735611     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-9-138     Document Type: Article

References (41)

1. Obesity: a growing problem. JC Seidell, Acta Paediatr Suppl 1999 88 46 50 10.1111/j.1651-2227.1999.tb14350.x 10102051 (Pubitemid 29108403)
2. Body weight: implications for the prevention of coronary heart disease, stroke, and diabetes mellitus in a cohort study of middle aged men. AG Shaper SG Wannamethee M Walker, BMJ 1997 314 1311 7 9158466
3. Overweight, underweight, and mortality. A prospective study of 48,287 men and women. JC Seidell WM Verschuren EM van Leer D Kromhout, Arch Intern Med 1996 156 958 63 10.1001/archinte.156.9.958 8624176
4. Past history of obesity (overweight by WHO criteria) is associated with an increased risk of nonfatal acute myocardial infarction: a case-control study in Japan. M Washio R Hayashi Fukuoka Heart Study Group, Circ J 2004 68 41 6 10.1253/circj.68.41 14695464
5. Effect of weight loss on blood pressure and insulin resistance in normotensive and hypertensive obese individuals. HY Su WH Sheu HM Chin CY Jeng YD Chen GM Reaven, Am J Hyperten 1995 8 1067 71 10.1016/0895-7061(95)00330-R
6. the D.E.S.I.R. Study group. Weight change and changes in the metabolic syndrome as the French population moves towards overweight: the D.E.S.I.R. cohort. TA Hillier A Fagot-Campagna E Eschwège S Vol M Cailleau B Balkau, Int J Epidemiol 2006 35 190 6 16373378 10.1093/ije/dyi281
7. Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. E Ferrannini SM Haffner BD Mitchell MP Stern, Diabetologia 1991 34 416 22 10.1007/BF00403180 1884900
8. Weight gain and the risk of developing insulin resistance syndrome. SA Everson DE Goldberg SP Helmrich TA Lakka JW Lynch GA Kaplan JT Salonen, Diabetes Care 1998 21 1637 43 10.2337/diacare.21.10.1637 9773723
9. Obesity, weight change and risks for hypertension, diabetes and hypercholesterolemia in Japanese men. K Ishikawa-Takata T Ohta K Moritaki T Gotou S Inoue, Eur J Clin Nutr 2002 56 601 7 10.1038/sj.ejcn.1601364 12080398
10. Impact of weight loss on the metabolic syndrome. CC Case PH Jones K Nelson E O'Brian Smith CM Ballantyne, Diabetes Obes Metab 2002 4 407 14 10.1046/j.1463-1326.2002.00236.x 12406040
11. Effect of orlistat, micronised fenofibrate and their combination on metabolic parameters in overweight and obese patients with the metabolic syndrome: the FenOrli study. TD Filippatos DN Kiortsis EN Liberopoulos M Georgoula DP Mikhailidis MS Elisaf, Curr Med Res Opin 2005 21 1997 2006 10.1185/030079905X75078 16368051
12. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial. TJ Orchard M Temprosa R Goldberg S Haffner R Ratner S Marcovina S Fowler Diabetes Prevention Program Research Group, Ann Intern Med 2005 142 611 9 15838067
13. The effect of sex, age and race on estimating percentage body fat from body mass index: The Heritage Family Study. SA Everson DE Goldberg SP Helmrich TA Lakka JW Lynch GA Kaplan JT Salonen, Int J Obes Relat Metab Disord 2002 26 789 96 10.1038/sj.ijo.0802006 12037649
14. A prospective study of adiposity and all-cause mortality: the Malmö Diet and Cancer Study. PH Lahmann L Lissner B Gullberg G Berglund, Obes Res 2002 10 361 9 10.1038/oby.2002.50 12006635
15. Temporal changes in anthropometric parameters and lipid profile according to body mass index among an adult Iranian urban population. MR PJ.Bozorgmanesh F Hadaegh M Padyab Y Mehrabi F Azizi, Ann Nutr Metab 2008 53 13 22 10.1159/000152869 18772585
16. Prevalence of metabolic syndrome in Iranian adult population, concordance between the IDF with the ATPIII and the WHO definitions. A Zabetian F Hadaegh F Azizi, Diabetes Res Clin Pract 2007 77 251 7 10.1016/j.diabres.2006.12.001 17234299
17. Cardiovascular risk factors in an Iranian urban population: Tehran lipid and glucose study (phase 1). F Azizi M Rahmani H Emami P Mirmiran R Hajipour M Madjid J Ghanbili A Ghanbarian Y Mehrabi N Saadat P Salehi N Mortazavi P Heydarian N Sarbazi S Allahverdian N Saadati E Ainy S Moeini, Soz Praventivmed 2002 47 408 26 12643001
18. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults, JAMA 2001 285 2486 97 10.1001/jama.285.19.2486 11368702
19. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. SM Grundy JI Cleeman SR Daniels KA Donato RH Eckel BA Franklin, Circulation 2005 112 2735 52 10.1161/CIRCULATIONAHA.105.169404 16157765
20. Determinants and definition of abdominal obesity as related to risk of diabetes, metabolic syndrome and coronary disease in Turkish men: a prospective cohort study. A Onat I Sari G Hergenç M Yazici H Uyarel G Can V Sansoy, Atherosclerosis 2007 191 182 90 10.1016/j.atherosclerosis.2006.03.012 16678831
21. Predictors of abdominal obesity and high susceptibility of cardiometabolic risk to its increments among Turkish women: a prospective population-based study. A Onat I Sari G Hergenç M Yazici H Uyarel G Can V Sansoy, Metabolism 2007 56 348 56 10.1016/j.metabol.2006.10.016 17292723
22. Body mass index (BMI) as a major factor in the incidence of the metabolic syndrome and its constituents in unaffected Taiwanese from 1998 to 2002. FY Yang ML Wahlqvist MS Lee, Asia Pac J Clin Nutr 2008 17 339 51 18586657
23. Metabolic syndrome and the development of CKD in American Indians: the Strong Heart Study. J Lucove S Vupputuri G Heiss K North M Russell, Am J Kidney Dis 2008 51 21 8 10.1053/j.ajkd.2007.09.014 18155529
24. Prevalence and incidence of the metabolic syndrome in the European Lacidipine Study on Atherosclerosis (ELSA) and its relation with carotid intima-media thickness. A Zanchetti M Hennig H Baurecht R Tang C Cuspidi S Carugo G Mancia, J Hypertens 2007 25 2463 70 10.1097/HJH.0b013e3282f063d5 17984668
25. Long-term body weight fluctuation is associated with metabolic syndrome independent of current body mass index among Japanese men. H Zhang K Tamakoshi H Yatsuya C Murata K Wada R Otsuka N Nagasawa M Ishikawa K Sugiura K Matsushita Y Hori T Kondo H Toyoshima, Circ J 2005 69 13 8 10.1253/circj.69.13 15635195
26. Intentional weight loss and death in overweight and obese U.S. adults 35 years of age and older. EW Gregg RB Gerzoff TJ Thompson DF Williamson, Ann Intern Med 2003 138 383 9 12614090
27. Predictors of the incident metabolic syndrome in adults: the Insulin Resistance Atherosclerosis Study. L Palaniappan MR Carnethon Y Wang AJ Hanley SP Fortmann SM Haffner L Wagenknecht Insulin Resistance Atherosclerosis Study, Diabetes Care 2004 27 788 93 10.2337/diacare.27.3.788 14988303
28. Prevalence of metabolic syndrome in Iranian adult population, concordance between the IDF with the ATPIII and the WHO definitions. A Zabetian F Hadaegh F Azizi, Diabetes Res Clin Pract 2007 77 251 7 10.1016/j.diabres.2006.12.001 17234299
29. Trends in serum lipids and lipoproteins of adults, 1960-2002. MD Carroll DA Lacher PD Sorlie JI Cleeman DJ Gordon M Wolz SM Grundy CL Johnson, JAMA 2005 294 1773 81 10.1001/jama.294.14.1773 16219880
30. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. L Sjöström AK Lindroos M Peltonen J Torgerson C Bouchard B Carlsson S Dahlgren B Larsson K Narbro CD Sjöström M Sullivan H Wedel Swedish Obese Subjects Study Scientific Group, N Engl J Med 2004 351 2683 93 10.1056/NEJMoa035622 15616203
31. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. K Esposito A Pontillo C Di Palo G Giugliano M Masella R Marfella D Giugliano, JAMA 2003 289 1799 804 10.1001/jama.289.14.1799 12684358
32. Can sustained weight loss in overweight individuals reduce the risk of diabetes mellitus? LL Moore AJ Visioni PW Wilson RB D'Agostino WD Finkle RC Ellison, Epidemiology 2000 11 269 73 10.1097/00001648-200005000-00007 10784242
33. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. J Tuomilehto J Lindström JG Eriksson TT Valle H Hämäläinen P Ilanne-Parikka S Keinänen-Kiukaanniemi M Laakso A Louheranta M Rastas V Salminen M Uusitupa Finnish Diabetes Prevention Study Group, N Engl J Med 2001 344 1343 50 10.1056/NEJM200105033441801 11333990
34. Effect of lifestyle intervention on metabolic coronary heart disease risk factors in obese older adults. DT Villareal BV Miller 3rd M Banks L Fontana DR Sinacore S Klein, Am J Clin Nutr 2006 84 1317 23 17158411
35. Metabolic syndrome: do clinical criteria identify similar individuals among overweight premenopausal women? S Alhassan A Kiazand RR Balise AC King GM Reaven CD Gardner, Metabolism 2008 57 49 56 18078858 10.1016/j.metabol.2007.08. 006
36. Sex difference in development of diabetes and cardiovascular disease on the way from obesity and metabolic syndrome. A Onat G Hergenç I Kele Y Doan S Türkmen V Sansoy, Metabolism 2005 54 800 8 10.1016/j.metabol.2005. 01.025 15931618
37. Weight history of patients with newly diagnosed Type 2 diabetes. N de Fine Olivarius B Richelsen V Siersma AH Andreasen H Beck-Nielsen, Diabet Med 2008 25 933 41 10.1111/j.1464-5491.2008.02472.x 18959606
38. First nationwide survey of prevalence of overweight, underweight, and abdominal obesity in Iranian adults. M Janghorbani M Amini WC Willett M Mehdi Gouya A Delavari S Alikhani A Mahdavi, Obesity 2007 15 2797 808 10.1038/oby.2007.332 18070771
39. Physical activity, body mass index, and risk of type 2 diabetes in patients with normal or impaired glucose regulation. G Hu J Lindström TT Valle JG Eriksson P Jousilahti K Silventoinen Q Qiao J Tuomilehto, Arch Intern Med 2004 164 892 6 10.1001/archinte.164.8.892 15111376
40. High prevalence of undiagnosed diabetes and abnormal glucose tolerance in the Iranian urban population: Tehran Lipid and Glucose Study. F Hadaegh MR Bozorgmanesh A Ghasemi H Harati N Saadat F Azizi, BMC Public Health 2008 24 8 176 10.1186/1471-2458-8-176
41. Interrelationship between insulin resistance and menopause on the metabolic syndrome and its individual component among nondiabetic women in the kinmen study. KC Lin ST Tsai SC Kuo SL Tsay P Chou, Am J Med Sci 2007 333 208 14 10.1097/MAJ.0b013e31803bb22c 17435412